Polymer Factory Enters Material Transfer Agreement with Thermo Fisher Scientific
Polymer Factory Sweden AB has entered into a Material Transfer Agreement (MTA) with Thermo Fisher Scientific, a global leader in analytical instruments, life sciences, and laboratory solutions.
The agreement establishes a framework for evaluating materials and potential calibration products based on Polymer Factory’s proprietary SpheriCal® technology platform. Under the agreement, the parties will explore selected product concepts and application areas within analytical instrumentation and mass spectrometry.
SpheriCal® is Polymer Factory’s patented dendritic polymer technology developed to provide highly defined calibration standards for advanced analytical workflows. The platform has been designed to address challenges associated with calibration accuracy, reproducibility, and instrument performance in modern analytical applications.
The agreement reflects growing industry interest in advanced calibration solutions and provides an opportunity to evaluate how SpheriCal® can address emerging analytical needs.
“Collaborations with leading industrial companies are an important part of our strategy to broaden the commercial reach of our technology platforms,” said Mats Wallnér, CEO of Polymer Factory. “Thermo Fisher Scientific is a highly respected organization within analytical sciences, and we are pleased to establish this framework for evaluating SpheriCal® in new application areas. We look forward to exploring the possibilities that this collaboration may create.”
Polymer Factory continues to focus on expanding the application base for its proprietary technologies through collaborations with industry, academia, and commercial partners. The Company believes that strategic partnerships play an important role in identifying new opportunities and accelerating the adoption of innovative analytical solutions.
The agreement does not include any immediate commercial commitments or guaranteed revenues but provides a structured basis for evaluation and potential future discussions between the parties.
This disclosure contains information that Polymer Factory is obliged to make public pursuant to the EU Market Abuse Regulation (EU nr 596/2014). The information was submitted for publication, through the agency of the contact person, on 10-06-2026 09:00 CET.
For more information, please contact:
Mats Wallnér, CEO
Phone: +46 (0) 70 951 95 06
E-mail: mats.wallner@polymerfactory.com
Polymer Factory (publ) is a leading global provider and producer of dendritic materials, with customers ranging from BigPharma, MedTech and BioTech companies, to research-intensive institutes and academic research groups. The Company’s dendritic materials act as smart delivery systems that enhance the effects of the substances they carry, e.g. a vaccine or an anticancer drug. They have also shown great promise in diagnostics, tissue engineering and in the development of vaccines. In addition, Polymer Factory has used the Company’s vast knowledge and expertise to develop a patented calibration technology, named SpheriCal®, designed for Mass Spectrometry instruments. The Company’s dendritic nanotechnologies have the potential to accelerate innovation in technologically demanding sectors, such as MedTech and BioTech. Learn more at www.polymerfactory.com.